Success stories 25 Mayo 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News 18 Nov 2020 Lonza manufactures coronavirus vaccine for Moderna Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the initial results...
News 11 Ago 2020 Moderna driving forward production of vaccine from Basel The Swiss government has just signed a supply contract with Moderna for 4.5 million doses of a coronavirus vaccine. The US company is now opening...
News 27 Ago 2020 Greater Zurich confirms quality of its location in times of COVID-19 The Greater Zurich Area remains a first-class location even in difficult times. Its innovative strength and diversification continue to benefit e...
News 23 Mayo 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
News 30 Sep 2021 Hamilton develops new swab device The medtech company Hamilton has developed an automated device for nasal and buccal swab collection in collaboration with the Harvard spin-off Rh...
Actualités 09 Jun 2020 La Suisse est le pays qui offre la plus grande sécurité contre le Covid-19 D’après une étude internationale, la Suisse est le pays au monde où l’on est le mieux protégé contre le coronavirus. Cela tient surtout à la rési...
News 10 Nov 2020 Memo Therapeutics raises 14 million Swiss francs The biotechnology company Memo Therapeutics has raised a total of 14 million Swiss francs as part of a Series B financing round. This should now ...
News 08 Sep 2020 EPFL spin-off Technis raises CHF 3.2 million for its connected floors The Vaud-based start-up and EPFL spin-off Technis has raised CHF 3.2 million for its connected floors that allow the flow of people to be regulat...
News 30 Mar 2020 University of Basel investigating active substances against the coronavirus The University of Basel is using computer-aided methods in its efforts to find an active substance to fight the coronavirus. A total of just unde...
News 13 Mayo 2020 Neovii developing COVID-19 vaccine The biotech company Neovii Pharmaceuticals AG has agreed on a collaboration with Tel Aviv University. Together, both partners hope to develop a v...
News 29 Abr 2020 Molecular Partners develops treatment for COVID-19 The biotechnology firm Molecular Partners has launched a therapy program to combat COVID-19. The company has developed artificial proteins aimed ...
News 07 Abr 2020 Artificial intelligence used to recruit patients The start-up Intrepida has developed an app based on Artificial Intelligence. This is aimed to help rapidly find potential participants in clinic...
News 24 Mar 2020 Hamilton ventilator production in full swing The American high-tech company Hamilton has its European headquarters and its most important production site in the Greater Zurich Area. There, p...
Aktuell 28 Sep 2020 Zühlke-App hilft Briten in der Covid-19-Pandemie Der Innovationsdienstleister Zühlke hat das staatliche Gesundheitssystem NHS in England und Wales bei der Einführung einer Covid-19-App unterstüt...
News 21 Oct 2020 The SICHH launches a platform to simplify scientific communication A new scientific communication platform entitled "Connect People with Science" is being launched. Its primary purpose will be to improve and simp...
News 22 Sep 2021 Switzerland remains a global innovation leader Switzerland has once again topped the Global Innovation Index for this year. In so doing, the world intellectual property organization has determ...